New AIM admission: Arecor Therapeutics

Arecor Therapeutics takes existing pharma products and reformulates them for new uses or to make them more effective. This reduces the risk, compared with developing completely new drugs.

Arecor has secured partnerships for some products, but the insulin products for diabetes are being developed to the phase II clinical trial stage and then a partner will be sought.

Any of these products could address significant markets so if one becomes a commercial product, particularly an insulin prod...

You are unauthorized to view this page.

Latest News

More Articles Like This

Tagdiv Cloud library - template content.